Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study — WeB  

Multiple Sclerosis Clinical Trial

Official title: Moving MS Bladder Dysfunction Into the 21st Century: Developing Novel and Accessible Ways to Treat Dysfunction in the Home - a Three Month Single Arm Open Label Feasibility Pilot With Waitlist Control

Status Recruiting

Clinical Trial Summary

The goal is to investigate the feasibility and effects of adding "wearables for the bladder" devices to conventional pelvic floor physical therapy (PFPT) to bladder function, in people with multiple sclerosis (MS).

Clinical Trial Description

The participants baseline pelvic floor and bladder function will be assessed by a pelvic floor physical therapist as per standard care, and online MS-symptom questionnaires (i.e., quality of life, bladder bother/symptoms, falls, fatigue, depression). Participants will be trained on the maintenance and use of "wearable for the bladder" (WeB) devices. Participants will receive standard PFPT intervention care, and will be asked to further train using the WeB devices. 8-10 sessions will be conducted over telehealth or in person as per standard protocol. At 12 weeks, participants will return to clinic for pelvic floor and bladder function assessment.

A control group will receive standard PFPT intervention care as well as online MS-symptom questionnaires. ;

Related Conditions & MeSH terms

• Multiple Sclerosis
• Sclerosis
• Urinary Bladder, Overactive

• NCT number: NCT05715268
• Study type: Interventional
• Source: University of California, San Francisco
• Contact: Valerie J Block, DPTSc
• Phone: ?+1 (415) 502-7208
• Email: valerie.block@ucsf.edu
• Status: Recruiting
• Phase: N/A
• Start date: March 15, 2023
• Completion date: September 2024